SelectQuote, Inc. (NYSE:SLQT) Sees Large Growth in Short Interest

SelectQuote, Inc. (NYSE:SLQT - Get Free Report) saw a significant increase in short interest in February. As of February 28th, there was short interest totalling 2,180,000 shares, an increase of 38.9% from the February 13th total of 1,570,000 shares. Based on an average daily volume of 1,890,000 shares, the days-to-cover ratio is presently 1.2 days. Currently, 1.6% of the company's stock are sold short.

Wall Street Analyst Weigh In

Several research analysts recently commented on SLQT shares. Noble Financial upgraded shares of SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $4.00 price target on shares of SelectQuote in a research report on Friday, November 22nd.

SelectQuote Stock Down 0.7 %

NYSE SLQT traded down $0.03 during trading on Friday, hitting $3.79. The company's stock had a trading volume of 1,396,119 shares, compared to its average volume of 1,277,668. SelectQuote has a fifty-two week low of $1.48 and a fifty-two week high of $6.86. The company has a market cap of $651.57 million, a PE ratio of -42.06 and a beta of 1.13. The company has a debt-to-equity ratio of 2.10, a current ratio of 6.36 and a quick ratio of 6.36. The business's 50 day simple moving average is $4.38 and its 200-day simple moving average is $3.28.

SelectQuote (NYSE:SLQT - Get Free Report) last released its earnings results on Monday, February 10th. The company reported $0.30 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.21. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. On average, equities analysts anticipate that SelectQuote will post -0.07 EPS for the current fiscal year.

Remove Ads

Insider Activity at SelectQuote

In other SelectQuote news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total transaction of $272,000.00. Following the completion of the sale, the insider now directly owns 1,166 shares of the company's stock, valued at approximately $6,343.04. This represents a 97.72 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 11.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On SelectQuote

Large investors have recently made changes to their positions in the stock. Barclays PLC lifted its position in SelectQuote by 166.8% during the 3rd quarter. Barclays PLC now owns 198,357 shares of the company's stock worth $430,000 after acquiring an additional 124,005 shares during the period. JPMorgan Chase & Co. raised its stake in shares of SelectQuote by 36.9% in the third quarter. JPMorgan Chase & Co. now owns 429,656 shares of the company's stock worth $932,000 after purchasing an additional 115,865 shares during the last quarter. KCM Investment Advisors LLC acquired a new stake in shares of SelectQuote during the third quarter worth about $608,000. SG Americas Securities LLC boosted its position in SelectQuote by 10.5% in the fourth quarter. SG Americas Securities LLC now owns 91,508 shares of the company's stock valued at $340,000 after buying an additional 8,660 shares during the last quarter. Finally, Oppenheimer & Co. Inc. purchased a new stake in SelectQuote in the fourth quarter valued at approximately $47,000. 34.59% of the stock is owned by hedge funds and other institutional investors.

SelectQuote Company Profile

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.